Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Cadila scores FDA approval for BMS and Alvogen generics

July 3, 2018 Manufacturing and Production, Sales and Marketing Adolat, Alvogen, Bristol-Myers Squibb, Cadila, FDA, Questran, generics, pharma

Cadila Healthcare has announced that it has gained FDA final approval to market nifedipine ER tablets in the strengths of …
News
novartis_outside_1

Novartis secures US rights to Adamis’ epinephrine auto injector

July 3, 2018 Manufacturing and Production, Sales and Marketing Adamis, Novartis, Symjepi, US, auto injector, pharma

Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine auto injector Symjepi in the …
News
shutterstock_138095450

Unfazed by Trump, Pfizer hikes prices for 100 of its drugs

July 3, 2018 Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes

After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …
News
s_world_pills

Global manufacturing harmonisation: Towards a worldwide safety network

July 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing compliance, feature, manufacturing, manufacturing compliance, pharma

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …
Feature

EMA approves Cimzia for use in treating plaque psoriasis

July 2, 2018 Sales and Marketing Cimzia, EMA, UCB, indication, pharmaceutical

The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label extension for Cimzia …
News
roche__tree

Roche’s Tecentriq combo gives strong Phase 3 showing in triple negative breast cancer

July 2, 2018 Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma

Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …
News
astrazeneca-sign

AstraZeneca chalks up double Japanese approval in lung and breast cancer

July 2, 2018 Sales and Marketing AstraZeneca, Cancer, Imfinzi, NSCLD, breast cancer, lung cancer, lynparza, pharma

It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have …
News
takeda_usa_pharmaceuticals_u

Takeda’s Entyvio secures Japanese approval in ulcerative colitis

July 2, 2018 Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis

Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …
News
abbvie_0

AbbVie ordered to pay $448m over generic delays

July 2, 2018 Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma

A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Remicade, Roche, biosimilar Amgen, lung cancer, multiple sclerosis, pharma

Summer seems to be in full swing as we reach the end of June, so it’s time to look back …
News

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018 Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …
News

Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis

June 29, 2018 Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …
News

NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis

June 29, 2018 Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma

Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …
News
amazon

Amazon makes first move into healthcare with online pharmacy acquisition

June 28, 2018 Medical Communications, Sales and Marketing amazon, pharma, pharmacy

It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …
News

Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori

June 28, 2018 Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma

UK health watchdog NICE has given its approval for Roche’s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026